EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease

Kholoud I Eissa, Mona M Kamel, Lamia W Mohamed, Ahmed S Doghish iD, Radwan Alnajjar, Ahmed A Al-Karmalawy, Asmaa E Kassab iD

Drug Development Research · 2023-08 · 84 (5) · 937-961

DOI: 10.1002/ddr.22064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 17.04.2023. Verfasst von Kholoud I Eissa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 12 S‐substituted tetrahydrobenzothienopyrimidines were designed and synthesized based on the donepezil scaffold. All the newly synthesized compounds were evaluated for their acetylcholinesterase (AChE) inhibitory activity and the most active compounds were tested for their butyrylcholinesterase (BuChE) inhibitory activity. Moreover, all the synthesized compounds were evaluated for their inhibitory effects against A β aggregation and antioxidant activity using the oxygen radical absorbance capacity method. Compounds 4b, 6b , and 8b displayed the most prominent AChE inhibitory action comparable to donepezil. Compound 6b showed the greatest AChE inhibitory action (IC 50 = 0.07 ± 0.003 µM) and the most potent BuChE inhibitory action (IC 50 = 0.059 ± 0.004 µM). Furthermore, the three compounds exhibited significant antioxidant activity. Compounds 6b and 8b exerted more inhibitory action on A β aggregation than donepezil. The cytotoxic activity of compounds 4b, 6b , and 8b against the WI‐38 cell line in comparison with donepezil was examined using 3‐(4,5‐dimethylthiazolyl‐2)‐2,5‐diphenyltetrazolium bromide assay. The results revealed that compounds 6b and 8b were less cytotixic than donepezil, while compound 4b showed nonsignificant cytotoxicity compared to donepezil. For more insights about the binding patterns of the most promising compounds ( 4b, 6b , and 8b ) with the AChE at molecular levels; molecular docking and molecular dynamics simulations were performed. The density functional theory calculations and absorption, distribution, metabolism, excretion and toxicity properties were described as well. The results highlighted compound 6b , which incorporates a phenylpiperazine moiety coupled to a thienopyrimidone scaffold via two‐atom spacer, to be a promising multifunctional therapeutic agent for the treatment of Alzheimer's disease. It is a potent dual AChE and BuChE inhibitor. Furthermore, it had stronger A β aggregation inhibitory action than donepezil. Additionally, compound 6b exerted significant antioxidant activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansDonepezilAcetylcholinesteraseButyrylcholinesteraseMolecular Docking SimulationAntioxidantsCholinesterase InhibitorsStructure-Activity RelationshipDrug DesignPyrimidines

Stichwörter der Autor:innen

anti-Alzheimer'santibutyrylcholinesteraseanticholinesterasedonepezil (DNP)

Substanzen

DonepezilAcetylcholinesteraseButyrylcholinesteraseAntioxidantsCholinesterase InhibitorsthienopyrimidinePyrimidines

Autor:innen und Institutionen

  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo, Egypt.
  • Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City, Cairo, Egypt.
  • Department of Chemistry, Faculty of Science, University of Benghazi, Benghazi, Libya.
  • Faculty of Pharmacy, Libyan International Medical University, Benghazi, Libya.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Egypt.

ORCID-Profile: Ahmed S Doghish, Asmaa E Kassab

Zitieren

APA

Eissa, K. I., Kamel, M. M., Mohamed, L. W., Doghish, A. S., Alnajjar, R., Al-Karmalawy, A. A., & Kassab, A. E. (2023). Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease. Drug Development Research, 84(5), 937-961. https://doi.org/10.1002/ddr.22064

Vancouver

Eissa KI, Kamel MM, Mohamed LW, Doghish AS, Alnajjar R, Al-Karmalawy AA, et al. Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease. Drug Development Research. 2023;84(5):937-961. doi:10.1002/ddr.22064

BibTeX
@article{Eissa2023,
  author = {Eissa, Kholoud I and Kamel, Mona M and Mohamed, Lamia W and Doghish, Ahmed S and Alnajjar, Radwan and Al-Karmalawy, Ahmed A and Kassab, Asmaa E},
  title = {Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease},
  journal = {Drug Development Research},
  year = {2023},
  volume = {84},
  number = {5},
  pages = {937--961},
  doi = {10.1002/ddr.22064}
}
Kostenlos starten →